Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
68.32
-2.14 (-3.04%)
At close: Apr 3, 2025, 4:00 PM
65.25
-3.07 (-4.49%)
After-hours: Apr 3, 2025, 5:12 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $4.89 billion as of April 3, 2025. Its market cap has decreased by -2.25% in one year.
Market Cap
4.89B
Enterprise Value
3.80B
1-Year Change
-2.25%
Ranking
Category
Stock Price
$68.32
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $4.89B, an increase of 514.55%. That is a compound annual growth rate of 63.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 5.04B | -9.30% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.09B |
| UnitedHealth Group | 478.50B |
| Johnson & Johnson | 369.31B |
| AbbVie | 364.89B |
| Novo Nordisk | 307.98B |
| Abbott Laboratories | 228.39B |
| AstraZeneca | 227.81B |
| Merck & Co. | 220.07B |